医学
放化疗
宫颈癌
肿瘤科
内科学
程序性细胞死亡1
癌症
PD-L1
免疫疗法
作者
C H Wang,Lijun Liu,Xia Li,Jia Lei,Yiqian Li,Zhibo Shen,Huirong Shi,Yan Cheng
出处
期刊:Future Oncology
[Future Medicine]
日期:2024-06-03
卷期号:20 (20): 1415-1426
标识
DOI:10.1080/14796694.2024.2342241
摘要
The prognosis of high-risk, locally advanced cervical cancer (LACC) remains poor following concurrent chemoradiotherapy (CCRT). We investigated whether the effect of CCRT can be enhanced by programmed cell death protein 1 (PD-1) inhibitor.
科研通智能强力驱动
Strongly Powered by AbleSci AI